Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5879371 | The Journal of Pain | 2009 | 21 Pages |
Abstract
Evidence on prediction and identification of aberrant drug-related behaviors is limited. Although several screening instruments may be useful, evidence is sparse and primarily based on derivation studies, and methodological shortcomings exist in all studies. Research that performs external validation, uses standardized definitions for clinically relevant aberrant drug-related behaviors, and evaluates clinical outcomes associated with different assessment and monitoring strategies is needed.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Roger Chou, Gilbert J. Fanciullo, Perry G. Fine, Christine Miaskowski, Steven D. Passik, Russell K. Portenoy,